Translational paradigm of advanced nanoscale strategies for triple negative breast cancer (TNBC): mechanistic insights, metastatic pathways, and emerging theragnosis
Triple-negative breast cancer (TNBC) progression involves pathogenicity, metastatic dissemination, and molecular dysregulation. Advanced therapies offer targeted strategies to inhibit tumor growth, reduce metastasis, and improve therapeutic efficacy.
Authors
- Suresh Kumar Verma (ORCID: https://orcid.org/0000-0003-1029-9766)
- Srijeeta Pal (ORCID: https://orcid.org/0000-0003-3766-0638)
- Apoorv Kirti
- Shaikh Sheeran Naser (ORCID: https://orcid.org/0000-0002-7543-0297)
- Debidutta Barik
- Richeek Parashar
- SP. Asima
- Soumya Sonalisha
- Eliana B. Souto
Institutions
- University College Dublin (IE)
- KIIT University (IN)
Publication Details
- Journal
- Materials Advances
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1039/d5ma00866b
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Department of Biotechnology, Ministry of Science and Technology, India
- University College Dublin
- Kalinga Institute of Industrial Technology